MKI67 and neoplasm: However, researchers have experienced inability of the software to distinguish Ki‐67‐positive tumor cells from other Ki‐67‐labeling cell types like lymphocytes, endothelial cells, and stromal cells, cells with abundant background pigment (e.g., hemosiderin) or to detect all negative tumor nuclei [11, 15].